Speakers of WMS 2022 Congress

Keynote Speech - Mitochondrial Medicine : Present and Future Douglas C. Wallace, Children's Hospital of Philadelphia, USA

Recent Advances in Mitochondrial Transplantation Therapy James McCully, Boston Children’s Hospital, USA

Sonlicromanol in Primary Mitochondrial Disease MELAS Spectrum Disorders Jan Smeitink, Khondrion B.V., the Netherlands

Folic Acid Supplementation Improves Drosophila Parkin Loss-of-Function Phenotype and Decreases Mitochondrial Hydrogen Peroxide Levels in Vulnerable Dopaminergic Neurons Lori Buhlman, Midwestern University Glendale, USA

Mitochondrial and Photo-Medicine - Recent Clinical Applications Michael Weber, President of European Laser Academy, Germany

The Role of Extracellular Vesicles in Mitochondrial Quality Control Mechanisms Marc Germain, Université du Québec à Trois-Rivières, Canada

Mitochondrial, Exosomal miR137-COX6A2 in Schizophrenia Ines Khadimallah, Lausanne University Hospital, Switzerland

The Potential of Mitochondrial Genome Engineering  Pedro Silva-Pinheiro, University of Cambridge, United Kingdom

GM1 oligosaccharide as mitochondrial modulator: implications in neurological diseases  Maria Fazzari, University of Milano, Italy

A Novel PTD-mediated IVT-mRNA delivery platform developed for Protein Replacement Therapy for genetic/metabolic disorders Lefkothea C. Papadopoulou, Aristotle University of Thessaloniki, Greece

EV-Mitochondria as a Promising Therapeutic for Mitochondrial Dysfunction Devika S Manickam, Duquesne University, USA

Unlocking the potential of the mammalian electron transport chain Jessica Spinelli, Whitehead Institute for Biomedical Research, USA

Mitochondrial responses to a massive trauma-determinant of survival Marc G. Jeschke, University of Toronto, Canada

2-Deoxy-D-glucose couples mitochondrial DNA replication with mitochondrial fitness Ian J. Holt, Biodonostia Health Research Institute, Spain

Mitochondrial Transfer via MitoPunch Michael Teitell, University of California, USA

Mitochondrial targeting in aging and injury Raghavan Pillai Raju, Medical College of Georgia, USA

The Multiple Facets of the Mitochondria Shaping Protein Opa1 in Adipocytes: From Epigenetic to Tissue Plasticity Camilla Bean, University of Padova, Italy

Regulation of Mitochondrial Signaling in Cardiomyopathy During Sepsis Qun Sophia Zang, Loyola University Chicago Health Science Campus, USA

Mitochondria Transplantation Between Living Cells Julia A. Vorholt, ETH Zurich, Switzerland

A Non-canonical Tricarboxylic Acid Cycle Underlies Cellular Identity Paige Arnold, Memorial Sloan Kettering Cancer Center, USA

Noninvasive treatment of brain ischemia-reperfusion injury with near infrared light: working toward clinical implementation Maik Hüttemann, Wayne State University, USA

Autologous Mitochondrial Transplant for Cerebral Ischemia Melanie Walker, University of Washington Medical School, USA

The Impact of Mesenchymal Stromal Cell Extracellular Vesicles on Mitochondrial Dysfunction in Acute Respiratory Distress Syndrome Anna Krasnodembskaya, Queen's University Belfast, United Kingdom

Mitochondrial DNA as Extracellular Vesicle Cargo in Aging and Age-related Conditions Nicole Noren Hooten, National Institutes of Health, USA

Targeting the Mitochondrial Unfolded Protein Response in Prostate Cancer Dhyan Chandra, Roswell Park Comprehensive Cancer Center, USA

Mitochondria in Retinal Photoreceptors: More than Meets the Eye John Ball, National Institutes of Health, USA

Mitochondria Workshop

How to Evaluate Mitochondria Function? Naig Gueguen, Mitovasc Institute, Mitolab team, INSERM 1083, CNRS 6215, Centre Hospitalier Universitaire d’Angers, France

President's Note: Targeting Mitochondria 2022

On behalf of the Scientific Committee of the World Mitochondria Society (WMS), we are pleased to announce the organization of the 13th Annual Meeting of WMS on Targeting Mitochondria, which will be held on October 26-28, 2022 at the Steigenberger Hotel Am Kanzleramt, Berlin, Germany & Online.

After the great success of the 12thWMS Meeting in 2021 that was held virtually with interactive sessions for discussion, we are hoping that personal interactions among colleagues from around the world will be a major feature of our 13^th World Annual Meeting.

While we have just started working on the outline of our next conference edition, we will potentially discuss the following topics:

• Mitochondrial Dysfunctions and Dynamics in Chronic Diseases
• Mitochondria Transplantation and Transfer
• Extracellular Vesicles & Mitochondria: The Target
• Nuclear-Mitochondrial Interactions and their Effect on Longevity and Health
• Translational Therapies - Focus on Infrared Therapies
• WMS challenges in the Acceleration of Mitochondrial Medicine

Basic scientists working at the bench in the laboratory, physicians treating patients suffering from mitochondrial disorders as well as representatives of companies working on the commercialization of mitochondria-targeted therapies are all welcome to our conference. I assure anyone who is going to join us in this year's Congress in October 2022 that you won’t be disappointed!

We are looking forward to meeting you all!

All our warmest regards.

Prof. Volkmar Weissig President of the World Mitochondria Society Midwestern University, USA

Prof. Marvin Edeas,  Founder of the World Mitochondria Society Institut Cochin, INSERM U1016, University Paris Descartes, France

Speakers of WMS 2022 Congress

Welcome to Targeting Mitochondria 2021

On behalf of the Scientific Committee of the World Mitochondria Society (WMS), we are excited to announce that the 13^th World Annual Meeting of WMS on Targeting Mitochondria will be held as on for October 26-28, 2022 in Berlin, Germany.

After the great success of the 12^nd WMS Meeting in 2021 that was held virtually with interactive sessions for discussion, we are hoping that personal interactions among colleagues from around the world will be a major feature of our 13^th World Annual Meeting.

While we have just started working on the outline of our next conference edition, we will potentially discuss the following topics:

• Mitochondrial Dysfunctions and Dynamics in Chronic Diseases
• Mitochondria transplantation and mitochondrial transfer
• Extracellular vesicles, exosomes and mitochondria
• Mitochondria and Immunity – Covid-19 and Cancer
• Nuclear-Mitochondrial Interactions and their Effect on Longevity and Health
• Strategies to Target Mitochondria: Clinical Trials and Potential Mitochondria-based Therapies

Basic scientists working at the bench in the laboratory, physicians treating patients suffering from mitochondrial disorders as well as representatives of companies working on the commercialization of mitochondria-targeted therapies are all welcome to our conference. I assure anyone who is going to join us in this year's Congress in October 2022 that you won’t be disappointed!

We are looking forward to meeting you all!

All our warmest regards.

Prof. Volkmar Weissig President of the World Mitochondria Society Midwestern University, USA

Prof. Marvin Edeas,  Founder of the World Mitochondria Society Institut Cochin, INSERM U1016, University Paris Descartes, France